Related Experiment Video
Updated: Jul 12, 2026

Development and Application of Rapamycin-regulated Tyrosine Phosphatases
Published on: September 6, 2024
The tumor suppressor DAPK is reciprocally regulated by tyrosine kinase Src and phosphatase LAR
Won-Jing Wang1, Jean-Cheng Kuo, Wei Ku
1Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan.
Abstract:
Death-associated protein kinase (DAPK) is a calmodulin-regulated serine/threonine kinase and elicits tumor suppression function through inhibiting cell adhesion/migration and promoting apoptosis. Despite these biological functions, the signaling mechanisms through which DAPK is regulated remain largely elusive. Here, we show that the leukocyte common antigen-related (LAR) tyrosine phosphatase dephosphorylates DAPK at pY491/492 to stimulate the catalytic, proapoptotic, and antiadhesion/antimigration activities of DAPK. Conversely, Src phosphorylates DAPK at Y491/492, which induces DAPK intra-/intermolecular interaction and inactivation. Upon EGF stimulation, a rapid Src activation leads to subsequent LAR downregulation, and these two events act in synergism to inactivate DAPK, thereby facilitating tumor cell migration and invasion toward EGF. Finally, DAPK Y491/492 hyperphosphorylation is found in human cancers in which Src activity is aberrantly elevated. These results identify LAR and Src as a DAPK regulator through their reciprocal modification of DAPK Y491/492 residues and establish a functional link of this DAPK-regulatory circuit to tumor progression.
Insights
Leukocyte common antigen-related tyrosine phosphatase (LAR) dephosphorylates Death-associated protein kinase (DAPK), enhancing its tumor-suppressing activity. Conversely, Src kinase inactivates DAPK, promoting cancer cell migration and invasion.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Death-associated protein kinase (DAPK) is a serine/threonine kinase with tumor suppressor functions, inhibiting cell adhesion/migration and promoting apoptosis.
- The precise regulatory mechanisms governing DAPK activity remain largely unknown.
Purpose of the Study:
- To elucidate the signaling pathways regulating DAPK activity.
- To investigate the roles of leukocyte common antigen-related tyrosine phosphatase (LAR) and Src kinase in DAPK regulation.
- To establish a link between DAPK regulation and tumor progression.
Main Methods:
- Investigated the phosphorylation status of DAPK at Y491/492.
- Utilized biochemical assays to assess DAPK activity, dephosphorylation by LAR, and phosphorylation by Src.
- Examined the effects of EGF stimulation on Src, LAR, and DAPK activity in cancer cells.
- Analyzed DAPK phosphorylation in human cancer tissues.
Main Results:
- LAR tyrosine phosphatase dephosphorylates DAPK at pY491/492, stimulating its catalytic, proapoptotic, and antiadhesion/antimigration activities.
- Src kinase phosphorylates DAPK at Y491/492, leading to its inactivation.
- EGF stimulation activates Src and downregulates LAR, synergistically inactivating DAPK and promoting tumor cell migration.
- DAPK Y491/492 hyperphosphorylation correlates with elevated Src activity in human cancers.
Conclusions:
- LAR and Src act as key regulators of DAPK through reciprocal phosphorylation/dephosphorylation at Y491/492.
- This DAPK-regulatory circuit involving LAR and Src plays a critical role in facilitating tumor cell migration, invasion, and overall cancer progression.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Receptor Tyrosine Kinases
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Abnormal Proliferation
